FrequentPTPRK-RSPO3fusions andRNF43mutations in colorectal traditional serrated adenoma

• DOI: 10.1002/path.4709
• Publication Date: 2016-02-29T06:06:55Z
• Authors: Shigeki Sekine; Satoshi Yamashita; Taro Tanabe; Taiki Hashimoto; Hiroshi Yoshida; Hirokazu Taniguchi; Motohiro Kojima; Kazuya Shinmura; Yutaka Saito; Nobuyoshi Hiraoka; Toshikazu Ushijima; Atsushi Ochiai
• Keywords: Adenoma; Male; Oncogene Proteins; Hyperplasia; Ubiquitin-Protein Ligases; DNA Mutational Analysis; Receptor-Like Protein Tyrosine Phosphatases, Class 2; Intestinal Polyps; Sequence Analysis, DNA; DNA-Binding Proteins; Intestines; 03 medical and health sciences; Cell Transformation, Neoplastic; 0302 clinical medicine; Mutation; Humans; Female; Oncogene Fusion; Colorectal Neoplasms; Thrombospondins; Wnt Signaling Pathway; Aged

The molecular mechanisms underlying the serrated pathway of colorectal tumourigenesis, particularly those related to traditional serrated adenomas (TSAs), are still poorly understood. In this study, we analysed genetic alterations in 188 colorectal polyps, including hyperplastic polyps, sessile serrated adenomas/polyps (SSA/Ps), TSAs, tubular adenomas, and tubulovillous adenomas by using targeted next-generation sequencing and reverse transcription-PCR. Our analyses showed that most TSAs (71%) contained genetic alterations in WNT pathway components. In particular, PTPRK-RSPO3 fusions (31%) and RNF43 mutations (24%) were frequently and almost exclusively observed in TSAs. Consistent with the WNT pathway activation, immunohistochemical analysis showed diffuse and focal nuclear accumulation of β-catenin in 53% and 30% of TSAs, respectively. APC mutations were observed in tubular and tubulovillous adenomas and in a subset of TSAs. BRAF mutations were exclusively and frequently encountered in serrated lesions. KRAS mutations were observed in all types of polyps, but were most commonly encountered in tubulovillous adenomas and TSAs. This study has demonstrated that TSAs frequently harbour genetic alterations that lead to WNT pathway activation, in addition to BRAF and KRAS mutations. In particular, PTPRK-RSPO3 fusions and RNF43 mutations were found to be characteristic genetic features of TSAs. Copyright © 2016 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.